Breaking News, Promotions & Moves

Calluna Pharma Names CEO

Mark Gaffney offers 20+ years of experience in corporate strategy, business development, and operations in both private and public biotechnology companies.

Author Image

By: Charlie Sternberg

Associate Editor

Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, has appointed Mark Gaffney as Chief Executive Officer. Alongside this appointment, John Montana, who has been acting as the Company’s interim CEO, will return to his role as an Operating Partner at Forbion. About Mark Gaffney, CEO Gaffney brings over 20 years of experience in corporate strategy, business development, and operations in both private...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters